Literature DB >> 21039065

Usefulness of endoscopic ultrasonography (EUS) for selecting carcinoid tumors as candidates to endoscopic resection.

M J Varas1, J B Gornals, C Pons, J C Espinós, R Abad, F J Lorente, D Bargalló.   

Abstract

INTRODUCTION: Carcinoid tumors (CTs) represent the most common type of neuroendocrine tumors (NETs). Digestive CTs in the gastroduodenal and colorectal tracts may be assessed using endoscopy and echoendoscopy or endoscopic ultrasonography (EUS) with the goal of attempting local resection with curative intent without having recourse to surgery.
OBJECTIVE: Endpoints in this study included:--Assessing the usefulness of EUS for selecting CTs as candidates to endoscopic excision. --Assessing the effectiveness of local resection (complete carcinoid resection) and the safety (complications) of the technique involved. PATIENTS AND METHODS: OUr series included 18 patients (12 males and 6 females) with 23 tumors. Sixteen patients (10 males and 6 females) were selected, with age ranging from 40 to 81 years (mean: 57 years), biopsied, endoscopically treated digestive carcinoid tumors, and a previous negative extension study. Twenty-one 2-to-20-mm (mean size 8 mm) tumors were resected in 23 procedures. After endoscopy plus biopsy and echoendoscopy (EUS), excision was carried out with conventional polypectomy snare mucosectomy and submucosal injection with saline and/or adrenaline in most cases (15), and mucosectomy technique following lesion ligation with elastic bands for six cases. Two cases underwent transanal endoscopic surgery (TEM), one of them following non-curative polypectomy. A total of 23 local procedures were performed with the key goal of assessing efficacy (complete resection: CR) and safety (complications).
RESULTS: There were no severe complications except for the last gastric mucosectomy for a 6-mm carcinoid, where a miniperforation occurred that was solved by using 3 clips (1/23: 4.3%).EUS sensitivity was 94%. Complete resection was 90.5% (19/21).
CONCLUSIONS: The endoscopic mucosal resection of selected carcinoid tumors is a safe, effective technique. EUS is the technique of choice to select patients eligible for endoscopic resection (carcinoids smaller than 20 mm in superficial layers, with an unscathed muscularis propria and negative extension study).

Entities:  

Mesh:

Year:  2010        PMID: 21039065     DOI: 10.4321/s1130-01082010001000002

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  7 in total

Review 1.  Advances in endoscopic ultrasound imaging of colorectal diseases.

Authors:  Elena Tatiana Cârțână; Dan Ionuț Gheonea; Adrian Săftoiu
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

Review 2.  [Gastric neuroendocrine tumors. Endoscopic and surgical treatment].

Authors:  M B Niederle; B Niederle
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

Review 3.  Rectal Endoscopic Ultrasound in Clinical Practice.

Authors:  Stephen Hasak; Vladimir Kushnir
Journal:  Curr Gastroenterol Rep       Date:  2019-04-12

4.  Endoscopic ultrasound in gastroenteropancreatic neuroendocrine tumors.

Authors:  Michelle Kang Kim
Journal:  Gut Liver       Date:  2012-08-07       Impact factor: 4.519

5.  Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors.

Authors:  Cemal Yazici; Brian R Boulay
Journal:  World J Gastroenterol       Date:  2017-07-21       Impact factor: 5.742

Review 6.  Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Giuseppe Iabichino; Milena Di Leo; Monica Arena; Giovanni Giuseppe Rubis Passoni; Elisabetta Morandi; Francesca Turpini; Paolo Viaggi; Carmelo Luigiano; Luca De Luca
Journal:  World J Gastroenterol       Date:  2022-09-14       Impact factor: 5.374

7.  Endoscopic techniques for diagnosis and treatment of gastro-entero-pancreatic neuroendocrine neoplasms: Where we are.

Authors:  Roberta Elisa Rossi; Alessandra Elvevi; Camilla Gallo; Andrea Palermo; Pietro Invernizzi; Sara Massironi
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.